Moderna seeks US FDA authorization for updated COVID vaccine

Moderna seeks US FDA authorization for updated COVID vaccine Moderna said on Thursday it has completed a submission to the U.S. Food and Drug Administration seeking authorization for its updated COVID-19 vaccine to target the XBB.1.5 subvariant. Reuters Reuters

...

The submission from the company follows the FDA's advice last week to manufacturers that are updating their COVID-19 vaccines to develop monovalent shots to target XBB.1.5.

...